PACB

Peers: ILMN QSI TXG LAB TMO BRKR BNGO QGEN TWST SEER

| Held by: ARKE ARKK ARKG VTI IWM VXF IWO IBB SCHA VTWO

Index	RUT
Market Cap	771.54M
Enterprise Value	1.24B
Income	-131.39M
Sales	159.27M
Book/sh	-0.11
Cash/sh	0.76
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	485
IPO	Oct 27, 2010

P/E	-
Forward P/E	-
PEG	-
P/S	4.84
P/B	-
P/C	3.26
P/FCF	-
EV/EBITDA	-
EV/Sales	7.79
Quick Ratio	4.03
Current Ratio	4.92
Debt/Eq	-
LT Debt/Eq	-
Option/Short	Yes / Yes

EPS (ttm)	-0.43
EPS next Y	-0.45
EPS next Q	-0.13
EPS this Y	74.02%
EPS next Y	5.29%
EPS next 5Y	41.41%
EPS past 3/5Y	-9.18% -
Sales past 3/5Y	7.64% 15.19%
EPS Y/Y TTM	75.85%
Sales Y/Y TTM	2.02%
EPS Q/Q	-3.08%
Sales Q/Q	-1.91%
Earnings	Nov 04 AMC
EPS/Sales Surpr.	0.00% -2.31%

Insider Own	8.56%
Insider Trans	-2.52%
Inst Own	53.87%
Inst Trans	1.08%
ROA	-16.66%
ROE	-929.32%
ROIC	-19.56%
Gross Margin	34.29%
Oper. Margin	-101.67%
Profit Margin	-82.49%
SMA20	8.46%
SMA50	35.79%
SMA200	54.22%
Trades

Shs Outstand	310.81M
Shs Float	284.22M
Short Float	16.51%
Short Ratio	4.01
Short Interest	46.93M
52W High	3.43 -27.74%
52W Low	1.07 131.98%
Volatility	13.16% 13.38%
ATR (14)	0.27
RSI (14)	57.83
Beta	2.24
Rel Volume	1.01
Avg Volume	11.71M
Volume	7,814,768

Perf Week	17.64%
Perf Month	-1.11%
Perf Quarter	74.80%
Perf Half Y	55.14%
Perf YTD	32.74%
Perf Year	27.95%
Perf 3Y	-65.09%
Perf 5Y	-90.63%
Perf 10Y	-70.87%
Recom	2.25
Target Price	2.54
Prev Close	2.90
Price	2.48
Change %	-14.41%

Consensus

Buy

Avg. Price Target

$2.54

Implied Upside

+2.3%

Analysts12incl. previous ratings

Rating Distribution6 Buy · 5 Hold · 1 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Sep 09, 2026	Resumed	UUBS	Neutral	$1.35	-45.6%
Mar 06, 2026	Downgrade	BBarclays	Equal Weight → Underweight	$1.50	-39.6%
Nov 11, 2024	Downgrade	UUBS	Buy → Neutral
Jun 03, 2024	Resumed	JJefferies	Buy	$4	+61.1%
Apr 22, 2024	Downgrade	JJP Morgan	Overweight → Neutral
Apr 18, 2024	Downgrade	GGoldman	Buy → Neutral	$7 → $2.50	+0.7%
Dec 14, 2023	Initiated	SStephens	Overweight	$11	+343.2%
Dec 14, 2023	Initiated	GGuggenheim	Neutral
Dec 13, 2023	Initiated	WWolfe Research	Peer Perform
Nov 17, 2023	Upgrade	UUBS	Neutral → Buy	$13 → $10	+302.9%
Oct 31, 2023	Upgrade	CCantor Fitzgerald	Neutral → Overweight	$11	+343.2%
Sep 28, 2023	Initiated	BBernstein	Outperform	$11	+343.2%
Jul 05, 2023	Resumed	JJP Morgan	Overweight	$13	+423.7%
Jun 30, 2023	Initiated	GGoldman	Buy	$17	+584.9%
May 10, 2023	Initiated	BBarclays	Equal Weight	$14	+464.0%
Mar 31, 2023	Upgrade	TTD Cowen	Market Perform → Outperform	$13 → $15	+504.3%
Feb 02, 2023	Initiated	UUBS	Neutral	$13	+423.7%
Jan 20, 2023	Downgrade	CCantor Fitzgerald	Overweight → Neutral	$12	+383.4%
Jan 05, 2023	Initiated	BScotiabank	Sector Outperform	$12	+383.4%
Jan 21, 2022	Resumed	CCantor Fitzgerald	Overweight	$62 → $31	+1,148.9%

Oct-27-26 06:58PM	PacBio's SPARCnext Transition Faces Its First Real Test After Three Straight Guidance Cuts (Earnings Whispers) +8.89% +15.51%
04:05PM	PacBio to Participate in Upcoming Investor Conferences (GlobeNewswire)
Oct-19-26 09:05AM	PacBio and Verily Health Announce Multi-Year Strategic Collaboration to Scale Long-Read Genomics for Biomedical AI (GlobeNewswire) +6.36%
Oct-14-26 04:05PM	PacBio to Report Third Quarter 2026 Financial Results on November 4, 2026 (GlobeNewswire)
Oct-06-26 11:51AM	PacBio Sinks 8% as TychoBio Endorses Its Highest Quality Biological Data the Real Story Is More Complicated (TIKR) -5.92%
09:05AM	Loading…
09:05AM	PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics (GlobeNewswire)
Oct-01-26 11:44AM	3 Biotech Stocks Put Traders Are Targeting Today (Schaeffer's Research) +5.91%
Sep-03-26 04:05PM	PacBio to Participate in the Morgan Stanley 24?? Annual Global Healthcare Conference (GlobeNewswire)
Aug-05-26 04:46PM	Pacific Biosciences: Q2 Earnings Snapshot (Associated Press) -9.72% -10.38%
04:08PM	PacBio Appoints Mark Van Oene as President and Chief Executive Officer (GlobeNewswire)
04:05PM	PacBio Announces Second Quarter 2026 Financial Results (GlobeNewswire)
09:05AM	PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system (GlobeNewswire)
Jul-28-26 04:05PM	PacBio to Participate in the Canaccord Genuity 46th Annual Growth Conference (GlobeNewswire)
Jul-15-26 04:05PM	PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026 (GlobeNewswire)
Jun-15-26 02:48PM	Cathie Wood Buys $444 Million in SpaceX, Dumps Tesla and AMD (GuruFocus.com)
09:05AM	Loading…
May-26-26 09:05AM	PacBio SPRQ-Nx Chemistry Now Shipping Worldwide, Enabling Sub-$300 HiFi Genomes for Large Scale Projects and AI-Enhanced Sequencing (GlobeNewswire)
May-21-26 04:05PM	PacBio to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire) +5.04%
May-19-26 09:00AM	Blank Bio Announces Seed Financing and Strategic Collaboration with PacBio to Advance RNA Foundation Models for Precision Oncology (Business Wire)
May-11-26 09:05AM	HiFi Solves Sub-fertility Consortium in Asia Pacific Reports First Major Study Using HiFi Long-Read Sequencing to Investigate Unexplained Subfertility and Recurrent Pregnancy Loss (GlobeNewswire)
May-07-26 04:33PM	Pacific Biosciences: Q1 Earnings Snapshot (Associated Press) -14.55%
04:05PM	PacBio Announces First Quarter 2026 Financial Results (GlobeNewswire)
Apr-21-26 09:05AM	PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing (GlobeNewswire)
Apr-16-26 04:05PM	PacBio to Report First Quarter 2026 Financial Results on May 7, 2026 (GlobeNewswire)
Apr-15-26 09:05AM	PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples (GlobeNewswire)
Mar-18-26 09:05AM	Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative (GlobeNewswire)
Mar-06-26 02:00PM	PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know (StockStory) -9.21%
09:14AM	COO Declines Despite Q1 Earnings Beat and Raised FY26 Outlook (Zacks)
Mar-05-26 10:57AM	Clover Health Enters Collaboration to Be Part of CMS Aligned Network (Zacks)
10:56AM	Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now (Zacks)
08:30AM	PacBio Announces the Appointment of Chris Gibson to the Board of Directors (GlobeNewswire)
09:20AM	Loading…
Mar-04-26 09:20AM	Here's Why You Should Retain Revvity Stock in Your Portfolio for Now (Zacks)
07:52AM	Intuitive Surgical Expands Direct Operational Presence in Europe (Zacks)
Mar-03-26 10:33PM	Life Sciences Tools & Services Stocks Q4 Recap: Benchmarking PacBio (NASDAQ:PACB) (StockStory) -6.17%
10:15AM	PacBio and DNAstack Collaborate on Global HiFi Genome Network Hub (Zacks)
Feb-27-26 04:15PM	PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know (StockStory) -5.62%
Feb-25-26 11:50AM	TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates (Zacks)
Feb-24-26 03:10PM	Why Is PacBio (PACB) Stock Soaring Today (StockStory) +5.06%
09:05AM	PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research (GlobeNewswire)
Feb-20-26 10:48AM	Genomics Stocks That Deserve a Place in Your Portfolio in 2026 (Zacks)
Feb-19-26 11:01PM	PacBio (PACB): Buy, Sell, or Hold Post Q4 Earnings? (StockStory)
12:35AM	5 Must-Read Analyst Questions From PacBio's Q4 Earnings Call (StockStory)
Feb-18-26 04:05PM	PacBio to Participate in the TD Cowen 46th Annual Health Care Conference (GlobeNewswire)
Feb-13-26 10:24AM	PacBio Q4 Earnings and Revenues Beat Estimates, Gross Margin Up (Zacks) -7.07%
08:21AM	PACB Q4 Deep Dive: Consumables and Clinical Adoption Drive Growth as SparkNex Launch Nears (StockStory)
12:03AM	Pacific Biosciences of California Inc (PACB) Q4 2025 Earnings Call Highlights: Strong Revenue ... (GuruFocus.com)
Feb-12-26 08:14PM	Pacific Biosciences of California Q4 Earnings Call Highlights (MarketBeat)
05:35PM	Pacific Biosciences of California (PACB) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
04:56PM	PacBio (NASDAQ:PACB) Reports Strong Q4 CY2025 (StockStory)
04:40PM	Pacific Biosciences: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	PacBio Announces Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
07:00AM	PacBio Joins iHope Initiative as First Long-Read Genomic Sequencing Partner (GlobeNewswire)
Feb-10-26 10:04PM	PacBio Earnings: What To Look For From PACB (StockStory)
Feb-02-26 09:05AM	PacBio Completes Sale of Short-Read Sequencing Assets (GlobeNewswire) -8.85%
Jan-30-26 06:15PM	Here's Why Pacific Biosciences of California (PACB) Fell More Than Broader Market (Zacks)
Jan-27-26 04:05PM	PacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 (GlobeNewswire) -7.39%
Jan-23-26 06:15PM	Pacific Biosciences of California (PACB) Stock Dips While Market Gains: Key Facts (Zacks)
Jan-16-26 06:15PM	Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know (Zacks) -5.96% +6.79%
Jan-15-26 10:35AM	PacBio Stock Up on HiFi Sequencing Adoption for Major SUDC Research (Zacks)
Jan-12-26 09:15AM	PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases (GlobeNewswire)
09:05AM	PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC) (GlobeNewswire)
09:05AM	PacBio Announces Preliminary Fourth Quarter and Full Year 2025 Revenue (GlobeNewswire)
Jan-09-26 11:20AM	PacBio Stock Dips Post Latest Launch to Expand Multiomics Capabilities (Zacks)
Jan-08-26 11:01PM	3 Reasons to Sell PACB and 1 Stock to Buy Instead (StockStory)
09:05AM	PacBio and UC Davis Researchers Introduce CiFi, a New Long-Read 3C Method That Enables Chromosome-Scale Assemblies from a Single SMRT Cell (GlobeNewswire)
Jan-07-26 06:15PM	Pacific Biosciences of California (PACB) Gains As Market Dips: What You Should Know (Zacks)
12:07PM	Here's Why You Should Add PacBio Stock to Your Portfolio (Zacks)
Jan-06-26 07:06AM	Three Genomics Stocks Worth Tracking This Year (Zacks) +5.05%
Jan-05-26 12:23PM	ARK Invest Boosts Gene-Editing Bets While Cutting Consumer Tech Exposure (GuruFocus.com) +7.61%
Jan-02-26 11:01AM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)
08:00AM	Stocks making big moves this week: PacBio, Crocs, FuelCell Energy, AMC Entertainment, and ON24 (StockStory)
Dec-31-25 05:00PM	Why Is PacBio (PACB) Stock Soaring Today (StockStory) +8.09%
06:26AM	Cathie Wood Doubles Down on Biotech as 2025 Ends, Offloads Rocket Lab (GuruFocus.com)
Dec-30-25 11:49PM	Barclays Analyst Is Bullish On Pacific Biosciences of California, Inc. (PACB) (Insider Monkey)
04:05PM	PacBio to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-29-25 12:51PM	TSLA: Cathie Wood Dumps $30 Million Worth Tesla Stock (GuruFocus.com)
Dec-03-25 03:26PM	Why PacBio (PACB) Stock Is Up Today (StockStory)
Nov-28-25 09:05AM	PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire)
Nov-26-25 09:40AM	Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year? (Zacks) -9.13%
Nov-24-25 01:00PM	PacBio, Bristol-Myers Squibb, Oscar Health, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know (StockStory) +12.61%
Nov-18-25 08:48AM	Top 3 Genomics Stocks to Consider for Your Portfolio (Zacks) +5.10%
Nov-13-25 04:05PM	PacBio to Present at Upcoming Investor Conferences (GlobeNewswire) -6.32%
12:00PM	Pacific Biosciences (PACB) Upgraded to Buy: Here's Why (Zacks)
Nov-12-25 03:20PM	Why PacBio (PACB) Shares Are Getting Obliterated Today (StockStory) -6.45%
12:36AM	5 Revealing Analyst Questions From PacBio's Q3 Earnings Call (StockStory)
Nov-11-25 12:26PM	Why PacBio (PACB) Stock Is Up Today (StockStory) +5.68%
Nov-10-25 10:35PM	Spotting Winners: PacBio (NASDAQ:PACB) And Life Sciences Tools & Services Stocks In Q3 (StockStory)
Nov-06-25 01:19PM	PACB Stock Down Despite Q3 Earnings Beat Estimates, Revenues Down Y/Y (Zacks) -7.05%
12:33AM	PACB Q3 Deep Dive: Consumable Strength Offsets Instrument Headwinds, Clinical Expansion in Focus (StockStory)
Nov-05-25 06:30PM	Compared to Estimates, Pacific Biosciences (PACB) Q3 Earnings: A Look at Key Metrics (Zacks)
05:55PM	Pacific Biosciences of California (PACB) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:54PM	Pacific Biosciences: Q3 Earnings Snapshot (Associated Press Finance)
04:10PM	PacBio (NASDAQ:PACB) Reports Sales Below Analyst Estimates In Q3 Earnings (StockStory)
04:02PM	PacBio Announces Third Quarter 2025 Financial Results (GlobeNewswire)
09:05AM	HiFi Solves Consortium Publishes First Major Study Demonstrating the Clinical Research Power of PacBio HiFi Genomes (GlobeNewswire)
Nov-04-25 09:15AM	Pacific Biosciences (PACB) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks) -10.71%
09:05AM	PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China (GlobeNewswire)
Nov-03-25 10:07PM	PacBio Earnings: What To Look For From PACB (StockStory)
Oct-31-25 02:11PM	PacBio (PACB) Shares Skyrocket, What You Need To Know (StockStory) +20.62%
Oct-28-25 06:15PM	Pacific Biosciences of California (PACB) Stock Drops Despite Market Gains: Important Facts to Note (Zacks) -5.74%
Oct-24-25 02:36PM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Gibson James R II	See Remarks	Oct 06 '26	Option Exercise	1.18	500,000	590,000	1,745,663	Oct 08 04:07 PM
Gibson James R II	See Remarks	Oct 06 '26	Sale	3.11	661,815	2,056,921	1,083,848	Oct 08 04:07 PM
Jim Gibson	Officer	Oct 06 '26	Proposed Sale	2.87	661,815	1,899,409		Oct 06 04:23 PM
Van Oene Mark	See Remarks	Aug 17 '26	Sale	1.13	26,911	30,409	2,705,853	Aug 18 08:17 PM
MARK VAN OENE	Officer	Aug 17 '26	Proposed Sale	1.13	26,911	30,512		Aug 17 04:08 PM
Gibson James R II	See Remarks	Apr 01 '26	Sale	1.37	88,185	120,813	1,245,663	Apr 03 04:05 PM
JAMES GIBSON	Officer	Apr 01 '26	Proposed Sale	1.37	88,185	120,778		Apr 01 05:17 PM
HENRY CHRISTIAN O	See Remarks	Mar 03 '26	Sale	1.51	12,497	18,920	3,581,813	Mar 04 05:55 PM
Van Oene Mark	See Remarks	Mar 03 '26	Sale	1.51	6,504	9,847	2,243,634	Mar 04 05:54 PM
Farmer Michele	See Remarks	Mar 03 '26	Sale	1.51	2,979	4,510	305,948	Mar 04 05:54 PM
MARK D. VAN OENE	Officer	Mar 03 '26	Proposed Sale	1.51	6,504	9,849		Mar 03 04:24 PM
CHRISTIAN HENRY	Officer	Mar 03 '26	Proposed Sale	1.51	12,497	18,924		Mar 03 04:20 PM
Van Oene Mark	See Remarks	Feb 17 '26	Sale	1.58	129,790	204,549	1,797,745	Feb 19 08:33 PM
Van Oene Mark	See Remarks	Feb 18 '26	Sale	1.63	55,107	89,769	1,742,638	Feb 19 08:33 PM
HENRY CHRISTIAN O	See Remarks	Feb 17 '26	Sale	1.58	331,793	522,906	2,814,374	Feb 19 08:31 PM
HENRY CHRISTIAN O	See Remarks	Feb 18 '26	Sale	1.63	140,874	229,484	2,673,500	Feb 19 08:31 PM
Farmer Michele	See Remarks	Feb 17 '26	Sale	1.58	35,215	55,499	234,044	Feb 19 08:28 PM
Farmer Michele	See Remarks	Feb 18 '26	Sale	1.63	14,952	24,357	219,092	Feb 19 08:28 PM
MARK VAN OENE	Officer	Feb 17 '26	Proposed Sale	1.58	303,739	478,693		Feb 17 06:27 PM
CHRISTIAN HENRY	Officer	Feb 17 '26	Proposed Sale	1.58	606,312	955,548		Feb 17 06:25 PM

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

CEOMr. Mark Van Oene Ph.D.

CFO & Principal Accounting OfficerMr. James R. Gibson II

Senior Business Advisor & DirectorMr. Christian O. Henry M.B.A.

Co-FounderDr. Stephen Turner Ph.D.

Ph.D.Dr. Brett Atkins J.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Pacific Biosciences of California Inc

Upgrade your Finviz experience